ArticleVaccines2022

Chimeric Virus-like Particle-Based COVID-19 Vaccine Confers Strong Protection against SARS-CoV-2 Viremia in K18-hACE2 Mice.

Challika Kaewborisuth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.